Japanese clinical practice guidelines for vascular tumors, vascular malformations, lymphatic malformations, and Lymphangiomatosis 2022 - PubMed
5 hours ago
- #Vascular Anomalies
- #Evidence-Based Medicine
- #Clinical Guidelines
- Guidelines aimed at optimizing treatment for vascular tumors, vascular malformations, lymphatic malformations, and lymphangiomatosis using evidence-based medicine.
- A total of 38 clinical questions (CQs) were developed to address key clinical issues and treatment efficacy.
- Systematic reviews were conducted on literature from 1980 to December 2020 using PubMed and Japana Centra Revuo Medicina (JCRM).
- Recommendations cover various treatments including resection, sclerotherapy/embolization, drug therapy, laser therapy, radiotherapy, and conservative management.
- The guidelines also address factors like lesion location, symptoms, treatment timing, diagnostic tests, pathological diagnosis, and causal genes.
- Strength of evidence and recommendations were determined following the Medical Information Network Distribution Service (Minds) methodology.
- These guidelines are intended to improve outcomes by systematizing treatment approaches and confirming safety.